Close
Nordic 9Nordic 9

Ousia Pharma (private company)

Denmark ousiapharma.com
See something wrong or missing? Let us know
Offices:Copenhagen
Industry:BiotechHealth servicesPharma
Business model:B2B

Ousia Pharma is a biotech spin-out from the University of Copenhagen in Denmark developing novel peptide-drug conjugates for treatment of obesity and metabolic diseases.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Ousia Pharma

Name Criteria
France AbolerIS Pharma
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Denmark Acesion Pharma
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Athera
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden AttgeNO
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Cinclus Pharma
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Denmark Oui
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Netherlands Citryll
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Finland DelSiTech
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Gradientech
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden iCellate
55%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Top